EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS

Bibliographic Details
Main Authors: Mari Paz Serrano-Regal, Leticia Calahorra, Inmaculada Alonso-García, Ursula Boschert, Philipp Haselmayer, María Cristina Ortega, Isabel Machin-Diaz, Celia Camacho-Toledano, Jennifer García-Arocha, Diego Clemente
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:IBRO Neuroscience Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2667242123005353
_version_ 1797636420128473088
author Mari Paz Serrano-Regal
Leticia Calahorra
Inmaculada Alonso-García
Ursula Boschert
Philipp Haselmayer
María Cristina Ortega
Isabel Machin-Diaz
Celia Camacho-Toledano
Jennifer García-Arocha
Diego Clemente
author_facet Mari Paz Serrano-Regal
Leticia Calahorra
Inmaculada Alonso-García
Ursula Boschert
Philipp Haselmayer
María Cristina Ortega
Isabel Machin-Diaz
Celia Camacho-Toledano
Jennifer García-Arocha
Diego Clemente
author_sort Mari Paz Serrano-Regal
collection DOAJ
first_indexed 2024-03-11T12:35:03Z
format Article
id doaj.art-dc97177e5f804c3a870196ab8fda9aa9
institution Directory Open Access Journal
issn 2667-2421
language English
last_indexed 2024-03-11T12:35:03Z
publishDate 2023-10-01
publisher Elsevier
record_format Article
series IBRO Neuroscience Reports
spelling doaj.art-dc97177e5f804c3a870196ab8fda9aa92023-11-06T04:23:02ZengElsevierIBRO Neuroscience Reports2667-24212023-10-0115S272S273EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSISMari Paz Serrano-Regal0Leticia Calahorra1Inmaculada Alonso-García2Ursula Boschert3Philipp Haselmayer4María Cristina Ortega5Isabel Machin-Diaz6Celia Camacho-Toledano7Jennifer García-Arocha8Diego Clemente9Hospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, SpainMerck KGaA, Ares Trading Sa, Eysins, SwitzerlandMerck KGaA, Immunology, Darmstadt, GermanyHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, Spain; Centro de investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Neuroimmuno-repair Group, Madrid, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, Spain; Centro de investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Neuroimmuno-repair Group, Madrid, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, Spain; Centro de investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Neuroimmuno-repair Group, Madrid, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, SpainHospital Nacional de Parapléjicos, Neuroimmuno-repair Group., Toledo, Spain; Centro de investigación Biomédica en Red-Enfermedades Neurodegenerativas (CIBERNED), Neuroimmuno-repair Group, Madrid, Spainhttp://www.sciencedirect.com/science/article/pii/S2667242123005353
spellingShingle Mari Paz Serrano-Regal
Leticia Calahorra
Inmaculada Alonso-García
Ursula Boschert
Philipp Haselmayer
María Cristina Ortega
Isabel Machin-Diaz
Celia Camacho-Toledano
Jennifer García-Arocha
Diego Clemente
EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
IBRO Neuroscience Reports
title EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
title_full EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
title_fullStr EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
title_full_unstemmed EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
title_short EVOBRUTINIB TREATMENT REDUCES THE DAMAGE TO THE CNS AND INCREASES THE NUMBER OF CLASSICAL DENDRITIC CELLS IN EXPERIMENTAL MULTIPLE SCLEROSIS
title_sort evobrutinib treatment reduces the damage to the cns and increases the number of classical dendritic cells in experimental multiple sclerosis
url http://www.sciencedirect.com/science/article/pii/S2667242123005353
work_keys_str_mv AT maripazserranoregal evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis
AT leticiacalahorra evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis
AT inmaculadaalonsogarcia evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis
AT ursulaboschert evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis
AT philipphaselmayer evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis
AT mariacristinaortega evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis
AT isabelmachindiaz evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis
AT celiacamachotoledano evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis
AT jennifergarciaarocha evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis
AT diegoclemente evobrutinibtreatmentreducesthedamagetothecnsandincreasesthenumberofclassicaldendriticcellsinexperimentalmultiplesclerosis